Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(16 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California University of California Davis Comprehensive Cancer Center, Sacramento, California Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland Boston Medical Center, Boston, Massachusetts